Mark is a member of the Board of Directors of Sunshine Heart, a NASDAQ and ASX-listed company developing a treatment for heat failure; Osprey Medical Inc, an ASX-listed medical device company commercialising a coronary catheter system; and Pathway Therapeutics Inc, a clinical-stage oncology company based in San Francisco.